To date Australia has been somewhat of a spectator in the mounting global trade war, but further escalation threatens to drag Australia in.
A strong run in equities and fairly stable interest rates has brokers keen on the outlook for general insurers.
Beach Energy extends productive life with big increase in reserves.
Brokers have lifted their valuations for Resolute Mining post the release of the Syama definitive feasibility study.
AMP has lost a third of its value over the course of the Royal Commission. Is it now a bargain, or is the worst yet to come?
Stockbrokers are still not keen on buying Sigma Healthcare shares, though a capital return might change their view.
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.
Aurizon has re-confirmed FY18 guidance but signalled a deteriorating outlook for FY19. Broker attitudes vary widely, given the regulatory uncertainties hanging over the stock.
Many brokers consider Link Administration has become a compelling Buy after recently de-rating on the back of reform proposals and the loss of a major account.
Despite some positives in the FY18 results, brokers question the lack of organic growth in the Metcash food business and also whether a buyback is the appropriate use of the company’s cash.